Designed ankyrin repeat proteins for detecting prostate-specific antigen expression in vivo

Late-stage prostate cancer often acquires resistance to conventional chemotherapies and transforms into a hormone-refractory, drug-resistant, and non-curative disease. Developing non-invasive tools to detect the biochemical changes that correlate with drug efficacy and reveal the onset of drug resis...

Descripción completa

Detalles Bibliográficos
Autores principales: Gut, Melanie, Dreier, Birgit, Furler, Sven, Sobek, Jens, Plückthun, Andreas, Holland, Jason P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: RSC 2023
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320840/
https://www.ncbi.nlm.nih.gov/pubmed/37415866
http://dx.doi.org/10.1039/d3cb00010a

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320840/
https://www.ncbi.nlm.nih.gov/pubmed/37415866
http://dx.doi.org/10.1039/d3cb00010a

Ejemplares similares